MAI Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.8M | Buy |
614,061
+193,369
| +46% | +$5.06M | 0.06% | 266 |
|
|
2026
Q1 | $11.8M | Buy |
420,692
+14,038
| +3% | +$374K | 0.07% | 253 |
|
|
2025
Q4 | $10.1M | Buy |
406,654
+13,605
| +3% | +$343K | 0.06% | 270 |
|
|
2025
Q3 | $10M | Buy |
393,049
+28,163
| +8% | +$695K | 0.06% | 256 |
|
|
2025
Q2 | $8.84M | Sell |
364,886
-1,009,573
| -73% | -$23.5M | 0.06% | 256 |
|
|
2025
Q1 | $34.8M | Sell |
1,374,459
-5,149
| -0.4% | -$135K | 0.26% | 87 |
|
|
2024
Q4 | $36.6M | Buy |
1,379,608
+681,950
| +98% | +$18.5M | 0.27% | 87 |
|
|
2024
Q3 | $20.2M | Buy |
697,658
+11,381
| +2% | +$332K | 0.19% | 97 |
|
|
2024
Q2 | $19.2M | Sell |
686,277
-25,613
| -4% | -$705K | 0.19% | 97 |
|
|
2024
Q1 | $19.8M | Buy |
711,890
+74,983
| +12% | +$2.08M | 0.2% | 101 |
|
|
2023
Q4 | $18.3M | Buy |
636,907
+337,538
| +113% | +$10.2M | 0.24% | 85 |
|
|
2023
Q3 | $9.93M | Sell |
299,369
-11,224
| -4% | -$397K | 0.15% | 132 |
|
|
2023
Q2 | $11.4M | Sell |
310,593
-13,054
| -4% | -$508K | 0.17% | 119 |
|
|
2023
Q1 | $13.2M | Sell |
323,647
-12,497
| -4% | -$540K | 0.21% | 108 |
|
|
2022
Q4 | $17.2M | Buy |
336,144
+15,620
| +5% | +$749K | 0.29% | 77 |
|
|
2022
Q3 | $14M | Buy |
320,524
+53,338
| +20% | +$2.59M | 0.26% | 89 |
|
|
2022
Q2 | $14M | Buy |
267,186
+19,245
| +8% | +$981K | 0.27% | 87 |
|
|
2022
Q1 | $12.8M | Buy |
247,941
+497
| +0.2% | +$25.8K | 0.22% | 100 |
|
|
2021
Q4 | $14.6M | Buy |
247,444
+42,080
| +20% | +$2.08M | 0.24% | 95 |
|
|
2021
Q3 | $8.83M | Sell |
205,364
-196
| -0.1% | -$8.68K | 0.17% | 113 |
|
|
2021
Q2 | $8.05M | Buy |
205,560
+3,358
| +2% | +$131K | 0.16% | 121 |
|
|
2021
Q1 | $7.33M | Buy |
202,202
+17,440
| +9% | +$619K | 0.16% | 118 |
|
|
2020
Q4 | $6.8M | Buy |
184,762
+15,946
| +9% | +$585K | 0.17% | 115 |
|
|
2020
Q3 | $5.88M | Sell |
168,816
-1,724
| -1% | -$60.4K | 0.17% | 111 |
|
|
2020
Q2 | $5.29M | Buy |
170,540
+5,652
| +3% | +$192K | 0.17% | 110 |
|
|
2020
Q1 | $5.11M | Buy |
164,888
+3,084
| +2% | +$105K | 0.21% | 98 |
|
|
2019
Q4 | $6.01M | Buy |
161,804
+63,999
| +65% | +$2.28M | 0.19% | 102 |
|
|
2019
Q3 | $3.33M | Sell |
97,805
-13,506
| -12% | -$491K | 0.15% | 128 |
|
|
2019
Q2 | $4.58M | Buy |
111,311
+12,586
| +13% | +$500K | 0.21% | 111 |
|
|
2019
Q1 | $3.98M | Sell |
98,725
-6,150
| -6% | -$246K | 0.2% | 116 |
|
|
2018
Q4 | $4.34M | Buy |
104,875
+3,885
| +4% | +$161K | 0.25% | 99 |
|
|
2018
Q3 | $4.22M | Sell |
100,990
-10,639
| -10% | -$410K | 0.22% | 111 |
|
|
2018
Q2 | $3.84M | Buy |
111,629
+2,369
| +2% | +$81K | 0.21% | 119 |
|
|
2018
Q1 | $3.68M | Buy |
109,260
+6,335
| +6% | +$218K | 0.21% | 115 |
|
|
2017
Q4 | $3.54M | Sell |
102,925
-19,155
| -16% | -$653K | 0.2% | 117 |
|
|
2017
Q3 | $4.13M | Sell |
122,080
-59
| -0% | -$1.9K | 0.25% | 103 |
|
|
2017
Q2 | $3.89M | Sell |
122,139
-6,417
| -5% | -$202K | 0.25% | 104 |
|
|
2017
Q1 | $4.17M | Sell |
128,556
-17,313
| -12% | -$546K | 0.28% | 98 |
|
|
2016
Q4 | $4.5M | Buy |
145,869
+3,092
| +2% | +$94.4K | 0.33% | 91 |
|
|
2016
Q3 | $4.59M | Buy |
142,777
+7,011
| +5% | +$234K | 0.35% | 83 |
|
|
2016
Q2 | $4.54M | Sell |
135,766
-52,208
| -28% | -$1.67M | 0.35% | 80 |
|
|
2016
Q1 | $5.29M | Buy |
187,974
+9,156
| +5% | +$262K | 0.4% | 73 |
|
|
2015
Q4 | $5.48M | Buy |
178,818
+5,817
| +3% | +$183K | 0.42% | 72 |
|
|
2015
Q3 | $5.16M | Sell |
173,001
-6,243
| -3% | -$200K | 0.39% | 80 |
|
|
2015
Q2 | $5.7M | Buy |
179,244
+21,133
| +13% | +$689K | 0.38% | 82 |
|
|
2015
Q1 | $5.22M | Sell |
158,111
-3,636
| -2% | -$116K | 0.35% | 86 |
|
|
2014
Q4 | $4.78M | Sell |
161,747
-322
| -0.2% | -$9.23K | 0.34% | 81 |
|
|
2014
Q3 | $4.55M | Buy |
162,069
+36,688
| +29% | +$1.03M | 0.44% | 65 |
|
|
2014
Q2 | $3.53M | Buy |
125,381
+42,889
| +52% | +$1.22M | 0.34% | 77 |
|
|
2014
Q1 | $2.51M | Buy |
82,492
+9,568
| +13% | +$285K | 0.25% | 93 |
|
|
2013
Q4 | $2.12M | Sell |
72,924
-1,800
| -2% | -$52.4K | 0.22% | 93 |
|
|
2013
Q3 | $2.04M | Buy |
74,724
+10,806
| +17% | +$294K | 0.26% | 77 |
|
|
2013
Q2 | $1.7M | Buy |
+63,918
| New | +$1.77M | 0.22% | 83 |
|
Other funds holding PFE
MAI Capital Management's PFE Position: Q2 2026 in Review
MAI Capital Management increased its Pfizer (PFE) stake by 46% in Q2 2026, buying an estimated $5.06M and bringing the position to 614,061 shares worth $14.8M. The position accounts for 0.06% of the portfolio, ranked #266.
MAI Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $36.6M in Q4 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- MAI Capital Management held 614,061 shares of Pfizer worth $14.8M as of Q2 2026.
- MAI Capital Management bought 193,369 Pfizer shares in Q2 2026, an estimated $5.06M.
- Pfizer made up 0.06% of MAI Capital Management's portfolio in Q2 2026, its #266 holding.
- MAI Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- MAI Capital Management's Pfizer position peaked at $36.6M in Q4 2024.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.